BRUKINSA caps 80 mg bte 120 pce
8720598340105
CH-67998
L01EL03
Reimbursement limitations:
BRUKINSA.01
Leucémie lymphoïde chronique dès la 2è ligne (LLC, monothérapie)
En monothérapie pour le traitement de …
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
1.17 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4680.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2022
Authorization holder
BeOne Medicines I GmbH
4051 Basel
Authorization information
- Swissmedic authorization number
- 67998
- Drug name
- Brukinsa, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01EL03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/02/2022
- Authorization expiration date
- 07/02/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BRUKINSA caps 80 mg bte 120 pce
- Description (DE)
- BRUKINSA Kaps 80 mg Ds 120 Stk
- Market launch
- 08/02/2022
- Narcotic (BTM)
- No